The stock market is mixed Tuesday, with the Dow Jones Industrial Average up 0.02%, the Nasdaq down 0.54% and the S&P 500 down 0.20%. Today’s winners include a pharmaceutical company entering into a partnership with a competitor to develop a cancer drug and a retailer whose CEO is departing in the near future. Today’s sole loser is a drug company ending a study of a brain cancer drug.
These are Tuesday’s winners and loser.
Shares of Galena Biopharma, Inc (NASDAQ: GALE) are up 10.86% to $2.26 on trading volume of 5.4 million shares. The biopharmaceutical company has signed an agreement with Teva Pharmaceutical Industries Limited (NYSE: TEVA) to develop its cancer treatment, NeuVax. The 52-week high is $3.54.
Shares of Big Lots Inc. (NYSE: BIG) are up 7.67% to $30.19 on trading volume of 3.9 million shares. CEO Steve Fishman announced he is retiring in 2013 after eight years as head of the company. The 52-week high is $47.22.
Shares of Geron Corporation (NASDAQ: GERN) are down 27.70% to $1.07 on trading volume of 3.7 million shares. The company announced it is ending research on a drug candidate to treat brain cancer, which will result in the layoff of 40 of its 107 full-time staffers. Before Tuesday, the 52-week low was $1.21.
Follow him on Twitter: SWeigley